NEW YORK, NY / ACCESSWIRE / September 27, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Rentokil Initial plc ("Rentokil Initial plc") (NYSE:RTO) concerning possible violations of federal securities laws. Rentokil disclosed on September 11, 2024, that it expected full-year adjusted pretax profit of approximately £700 million, compared to £766 million in the previous year, citing weaker than expected sales in North America, the Company's largest market.
NEW YORK CITY, NY / ACCESSWIRE / September 27, 2024 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Rentokil Initial plc ("Rentokil" or "the Company") (NYSE:RTO). Investors who purchased Rentokil securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/RTO.
NEW YORK, NY / ACCESSWIRE / September 26, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Rentokil Initial plc ("Rentokil Initial plc") (NYSE:RTO) concerning possible violations of federal securities laws. Rentokil disclosed on September 11, 2024, that it expected full-year adjusted pretax profit of approximately £700 million, compared to £766 million in the previous year, citing weaker than expected sales in North America, the Company's largest market.
LOS ANGELES, CA / ACCESSWIRE / September 26, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Rentokil Initial plc ("Rentokil" or "the Company") (NYSE:RTO) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
NEW YORK, NY / ACCESSWIRE / September 26, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Rentokil Initial plc ("Rentokil Initial plc") (NYSE:RTO) concerning possible violations of federal securities laws. Rentokil disclosed on September 11, 2024, that it expected full-year adjusted pretax profit of approximately £700 million, compared to £766 million in the previous year, citing weaker than expected sales in North America, the Company's largest market.
NEW YORK CITY, NY / ACCESSWIRE / September 26, 2024 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Rentokil Initial plc ("Rentokil" or "the Company") (NYSE:RTO). Investors who purchased Rentokil securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/RTO.
LOS ANGELES, CA / ACCESSWIRE / September 25, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Rentokil Initial plc ("Rentokil" or "the Company") (NYSE:RTO) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
NEW YORK, NY / ACCESSWIRE / September 25, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Rentokil Initial plc ("Rentokil Initial plc") (NYSE:RTO) concerning possible violations of federal securities laws. Rentokil disclosed on September 11, 2024, that it expected full-year adjusted pretax profit of approximately £700 million, compared to £766 million in the previous year, citing weaker than expected sales in North America, the Company's largest market.
NEW YORK, NY / ACCESSWIRE / September 25, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Rentokil Initial plc ("Rentokil Initial plc") (NYSE:RTO) concerning possible violations of federal securities laws. Rentokil disclosed on September 11, 2024, that it expected full-year adjusted pretax profit of approximately £700 million, compared to £766 million in the previous year, citing weaker than expected sales in North America, the Company's largest market.
American depositary receipts (ADRs) of Rentokil Initial (RTO) gained Wednesday when the pest-control company announced that an executive from activist investor Nelson Peltz's Trian Fund Management hedge fund was appointed to its board.
NEW YORK, NY / ACCESSWIRE / September 25, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Rentokil Initial plc ("Rentokil Initial plc") (NYSE:RTO) concerning possible violations of federal securities laws. Rentokil disclosed on September 11, 2024, that it expected full-year adjusted pretax profit of approximately £700 million, compared to £766 million in the previous year, citing weaker than expected sales in North America, the Company's largest market.
NEW YORK CITY, NY / ACCESSWIRE / September 25, 2024 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Rentokil Initial plc ("Rentokil" or "the Company") (NYSE:RTO). Investors who purchased Rentokil securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/RTO.